Benita Tan Kiat Tee
Skip Ribbon Commands
Skip to main content
Menu
Clin Assoc Prof Tan Kiat Tee Benita (Benita Tan)

Clin Assoc Prof Benita Tan

MBBS (S'pore), MRCSEd, MMed (Surg), FRCS (Edin), FAMS, PhD (SSHSPH, NUS)

Senior Consultant

Sengkang General Hospital

Specialty: General Surgery, Breast Surgery

Clinical Interest: Breast Surgery, Oncoplastic Breast Surgery

Conditions Treated by this Doctor:
Atypical Hyperplasia, Benign Breast Change and Symptoms, Benign Breast Diseases, Benign Breast Neoplasms, Breast Cancer, Breast Cancer - Early Detection and Screening, Breast Cancer (Breast Health), Breast Cancer (Diagnosis to Treatment), Breast Clinical Assessment, Breast Infection, Breast Lumps, Breast Radiological Evaluation, Breast Reconstruction, Breast Screening – Self-Exam and Mammogram, Breast Surgery, Duct Ectasia, Fibroadenoma, Fibrocystic Change, Gynaecomastia, Hereditary Breast Cancer Syndromes, High Risk Breast Changes, Intraductal Papillomas, Lobular Carcinoma in Situ, Mastitis.

Clinical Appointments

  • Chairman Division of Surgery Sengkang General HospitalSengkang General Hospital
  • Senior Consultant Department of General Surgery Sengkang General HospitalSengkang General Hospital
  • Senior Consultant Breast Service Sengkang General HospitalSengkang General Hospital
  • Senior Consultant General Surgery Singapore General HospitalSingapore General Hospital
  • Senior Consultant Breast Surgery Singapore General HospitalSingapore General Hospital
  • Senior Consultant SingHealth Duke-NUS Breast Centre

Profile

Associate Professor Benita Tan is a Senior Consultant in the Department of General Surgery in Sengkang General Hospital, and the current Chairman of the Division of Surgery at Sengkang General Hospital. She is also a Senior Consultant at the Department of Breast Surgery, Singapore General Hospital and Division of Surgical Oncology in National Cancer Centre, Singapore. 

A/Prof Benita holds concurrent appointments serving various administrative positions in SingHealth and Sengkang General Hospital such as Member of the Academic Medicine Council for Surgery ACP as the Vice-chair of Fellowship and Professional Development (FAPD), Office of Academic & Clinical Development, Academic Development Department, (OACD, ADD), Duke-NUS Medical School, Co-chair of the SKH Office of Value based healthcare, Co-chair of the Singhealth Office of Sustainability and various others. She is also a Member of the Singapore Complaints Committee. A/Prof Tan also drives the Office of Value Based Healthcare looking to improve the value and outcomes of patient care. She is also passionate about the health of our environment, chairing the SKH Go Green committee since 2017, driving sustainability projects and events over the years and now extends that interest in the Singhealth cluster as the Co-chair of the Singhealth Office of Sustainability

A/Prof Tan graduated with a Bachelor of Medicine and Surgery in the National University of Singapore in 1995. She trained as a general surgeon, completed her Membership examination of the Royal College of Surgeons of Edinburgh in 1999 and obtained Master of Medicine (Surgery), National University of Singapore a year after in 2000. She continued to pursue the advanced specialty training in General Surgery and was accredited as a specialist in General surgery in 2003, with the Fellowship Examinations of the Royal College of Surgeons of Edinburgh (General Surgery), before sub-specializing in breast surgery in particular breast cancer surgery. She attained her Doctor of Philosophy, at Saw Swee Hock School of Public Health, National University of Singapore in 2013.

Her breast and surgical oncology practice covers breast cancer screening and detection, benign breast diseases, breast cancer evaluation, diagnosis, counselling, surgical management, and surveillance. Experienced in a wide range of breast procedures, she performs minimally invasive image-guided breast biopsies, breast lump and lesion excisions, localisation procedures under ultrasound, wire and radar guidance, oncological breast cancer surgeries such as breast conserving cancer surgery, including that with oncoplastic breast surgery such as mastopexy, mammoplasty, and intercostal artery perforator flaps, intraoperative radiotherapy, mastectomies including simple mastectomy, skin-sparing and nipple-sparing mastectomy and minimally-invasive endoscopic surgery with immediate (or delayed) breast reconstruction, sentinel lymph node biopsy, targeted axillary dissection, and axillary lymph node dissection/clearance. She works closely with a multidisciplinary team including breast radiologists, pathologists, medical oncologists, radiation oncologists, gynaecologists, genetic counsellors, specialist breast nurses, psychologists, occupational therapists, and plastic and reconstructive microsurgeons. She also manages patients for general surgical conditions, performs procedures, including laparoscopic surgery for other general surgical conditions. She has keen interest in keeping abreast with new surgical techniques to improve oncological outcomes and quality of life for her patients. She believes in importance of multidisciplinary approach in the delivering of personalised care to each patient and their loved ones through their treatment journey and survivorship.

Besides pursuing clinical excellence, A/Prof Tan is passionate about under- and post-graduate education and academic teaching.  She holds concurrent appointments of Associate Professor in the Yong Loo Lin School of Medicine, NUS, and Associate Professor with the Duke-NUS Medical School, and is the content expert, Clinical Teacher and Clinical Practice Facilitator for Lee Kong Chian School of Medicine. She is Physician Faculty for Singhealth’s Residency Programme in General Surgery and Family Medicine; and teaches in the Resident Nursing programme. She is actively involved in a wide range of breast and general surgery research, both clinical and translational, locally and internationally, and has numerous publications in peer reviewed international journals. 

Education

  • Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore
  • Member of the Royal College of Surgeons of Edinburgh (MRCSEd)
  • Master of Medicine (Surgery), National University of Singapore (MMed Surgery)
  • Fellow of the Royal College of Surgeons of Edinburgh (FRCSEd)
  • Fellow of the Academy of Medicine (FAMS), Singapore
  • Doctor of Philosophy (PhD), Saw Swee Hock School of Public Health, National University of Singapore

Professional Appointments and Committee Memberships

  • Clinical Associate Professor, SingHealth Duke-NUS Medical School, Yong Loo Lin School of Medicine
  • Content expert, Clinical Teacher and Clinical Practice Facilitator, Lee Kong Chian School of Medicine
  • Chairman, Division of Surgery, Medical Board
  • Member, SKOOP Editorial Committee
  • Member, Medical Audit Committee
  • SKH Scientific Review Committee
  • Member, SKH Quality and Risk Management Committee
  • Vice-Chair, Faculty Affairs and Professional Development (FAPD), Academic Medical Centre, SingHealth
  • Member, Singhealth Cluster eSignature Platform Steering Committee, Singhealth Cluster IT Council
  • Member, Singhealth Tissue Repository Tissue Release Committee
  • Member, Singhealth Tissue Repository Advisory Committee
  • Joy at Work Taskforce Transformation of ward rounds (JAW TF-WG)
  • Member, Strategy Retreat 2021 Group 2: Population Health Standing Committee
  • Member, Bundled Care & Capitation Workgroup, SingHealth, Regional Health System
  • Institution Lead for Partners Buddy Rollout at SKH, Singhealth
  • Co-Programme Director – Associate Consultant Readiness Programme (ACRP), Office of Academic & Clinical Development, Academic Development, Duke-NUS
  • Member of Junior Faculty Advisory Committee to Singhealth Duke-NUS Academic Council, OACD, Duke-NUS Medical School
  • Member of the Breast Cancer Clinician Workgroup, Value-Driven Care (VDC) Initiative, MOH
  • Member, Clinical Researcher, Asian Breast Cancer Network, Korean Breast Cancer Society
  • Member, Singapore Society of Oncology – Breast Cancer Group
  • Member, Singapore Medical Council, Complaints Committee

Awards

  • SingHealth Game Changer Award 2023
  • Singapore Health Quality Service Awards 2023 – Star Award
  • Singapore Health Quality Service Awards 2022 – Gold Award
  • You Sparkle Award 2022 – Gold Award
  • Long Service Medal
  • You Sparkle Award 2021 – Silver Award
  • Singapore Health Quality Service Awards 2021 – Hero Award
  • Outstanding Clinician Award, 2019
  • Certificate of Commendation, Role Model to the medical class of 2013, NUH
  • Service with a Heart Award, SGH – YR 2010, 2011, 2015
  • Singapore Totalisator Board Medical Research Fellowship, National Medical Research Council, Singapore, 2004

Research Interests

Publications

A strong believer of collaborative efforts and interest in breast cancer research, she works with local partners from National Cancer Centre, SingHealth Research, Genomic Institute of Singapore, Institute for Molecular and Cell Biology and the other local hospitals; as well as internationally with the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Universiti Malaya, Sun Yat-Sen Cancer Center, Asian Breast Cancer Network and the Cancer Genome Project, Wellcome Trust Sanger Institute.

1. Carcinoma of the rectum with a single penile metastasis. Tan BKT, Nyam DCNK, Ho YH. Singapore Med J. 2002 Jan;43(1):39–40.

2. Abdominal apoplexy: A potentially fatal enigma. Tan YM, Tan BKT, Chow PKH. ANZ J Surg. 2003 Jun;73(6):461–2.

3. Management of inpatients exposed to an outbreak of severe acute respiratory syndrome (SARS). Tan Y-M, Chow PKH, Tan B-H, Kurup A, Tan BKT, Tan FLS, Seldrup J, Heng DMK, Ang B, Green J, Wong C-Y, Soo K-C. J Hosp Infect. 2004 Nov;58(3):210–5.

4. Management of acute bleeding per rectum. Tan BKT, Tsang CBS, Nyam DCNK, Ho YH. Asian J Surg. 2004 Jan;27(1):32–8.

5. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Chen W, Salto-Tellez M, Palanisamy N, Ganesan K, Hou Q, Tan LK, Sii LH, Ito K, Tan B, Wu J, Tay A, Tan KC, Ang E, Tan BK, Tan PH, Ito Y, Tan P. Genes Chromosomes Cancer. 2007 Mar;46(3):288–301.

6. Clinical validation of a customized multiple signature microarray for breast cancer. Tan BKT, Tan LK, Yu K, Tan PH, Lee M, Sii LH, Wong CY, Ho GH, Yeo AWYY, Chow PKHH, Koong HN, Yong WS, Lim DTHH, Ooi LLPJPJ, Soo KC, Tan P. Clin Cancer Res. 2008 Jan 15;14(2):461–9.

7. Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Tan BKT, Lim GH, Czene K, Hall P, Chia KS. Breast Cancer Res. 2009 Jan;11(1):R4.

8. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH. Mod Pathol. 2010 Jan;23(1):123–33.

9. Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Thike AA, Iqbal J, Cheok PY, Chong APY, Tse GM-K, Tan B, Tan P, Wong NS, Tan PH. Am J Surg Pathol. 2010 Jul;34(7):956–64.

10. The landscape of cancer genes and mutational processes in breast cancer. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A, Karesen R, Schlichting E, Naume B, Sauer T, Ottestad L, Lee MTM, Shen C-YY, Tee BTK, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin S-FF, Thomas G, Boyault S, Mariani O, Lakhani SR, Van De Vijver M, Van’t Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SAJRJR, Salomon AV, Børresen-Dale A-LL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR, van ’t Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SAJRJR, Salomon AV, Børresen-Dale A-LL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR, Karesen R, Schlichting E, Naume B, Sauer T, Ottestad L, Lee MTM, Shen C-YY, Tan BKT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin S-FF, Thomas G, Boyault S, Mariani O, Lakhani SR, Van De Vijver M, Van’t Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SAJRJR, Salomon AV, Børresen-Dale A-LL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR. Nature. 2012 Jun 21;486(7403):400–4.

11. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, Menzies A, Roman-Garcia P, Fullam A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E, Knappskog S, Van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP, Nik-Zainal S, Alexandrov L, Behjati S, Yates LR, Bolli N, Mudie L, Hardy C, Martin S, McLaren S, O’Meara S, Anderson E, Maddison M, Gamble S, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C, Neal D, Lynch AG, Visakorpi T, Isaacs WB, van’t Veer L, Caldas C, Desmedt C, Sotiriou C, Aparicio S, Foekens JA, Eyfjörd JE, Lakhani SR, Thomas G, Myklebost O, Span PN, Børresen-Dale A-L, Richardson AL, Van de Vijver M, Vincent-Salomon A, Van den Eynden GG, Flanagan AM, Futreal PA, Janes SM, Bova GS, Stratton MR, McDermott U, Campbell PJ. Science. 2014 Aug 1;345(6196):1251343.

12. Assessment of suitability of the one step nucleic acid amplification (OSNA) assay as an intraoperative procedure for detection of metastasis in sentinel lymph nodes of breast cancer. Jara-Lazaro AR, Hussain IHM, Thike AA, Wong CY, Ho GH, Yong WS, Ong KW, Madhukumar P, Tan BKT, Oey CL, Hwang JSG, Tan PH. J Clin Pathol. 2014 Dec;67(12):1032–7.

13. Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: Clinical relevance and prognostic significance. Ahmed SS, Thike AA, Iqbal J, Yong WS, Tan B, Madhukumar P, Ong KW, Ho GH, Wong CY, Tan PH. J Clin Pathol. 2014 Mar 11;67(3):243–50.

14. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram. Chue KM, Yong WS, Thike AA, Ahmed SS, Li HH, Wong CY, Ho GH, Madhukumar P, Tan BKT, Ong KW, Tan PH. J Clin Pathol. 2014 Feb;67(2):112–9.

15. Contralateral prophylactic mastectomy in an Asian population: A single institution review. Sim Y, Tan VKM, Ho GH, Wong CY, Madhukumar P, Tan BKT, Yong WS, Ng YYR, Ong KW. Breast. 2014 Feb;23(1):56–62.

16. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Lim WK, Ong CK, Tan J, Thike AA, Ng CCY, Rajasegaran V, Myint SS, Nagarajan S, Nasir NDM, Mcpherson JR, Cutcutache I, Poore G, Tay ST, Ooi WS, Tan VKM, Hartman M, Ong KW, Tan BKT, Rozen SG, Tan P, Tan PH, Teh BT. Nat Genet. 2014 Aug;46(8):877–80.

17. Processed pseudogenes acquired somatically during cancer development. Cooke SL, Shlien A, Marshall J, Pipinikas CP, Martincorena I, Tubio JMCC, Li Y, Menzies A, Mudie L, Ramakrishna M, Yates L, Davies H, Bolli N, Bignell GR, Tarpey PS, Behjati S, Nik-Zainal S, Papaemmanuil E, Teixeira VH, Raine K, Oameara S, Dodoran MS, Teague JW, Butler AP, Iacobuzio-Donahue C, Santarius T, Grundy RG, Malkin D, Greaves M, Munshi N, Flanagan AM, Bowtell D, Martin S, Larsimont D, Reis-Filho JS, Boussioutas A, Taylor JA, Hayes ND, Janes SM, Futreal PA, Stratton MR, McDermott U, Campbell PJ, Provenzano E, van de Vijver M, Richardson AL, Purdie C, Pinder S, Grogan G Mac, Vincent-Salomon A, Larsimont D, Grabau D, Sauer T, Garred Ø, Ehinger A, Van den Eynden GG, van Deurzen CHM, Salgado R, Brock JE, Lakhani SR, Giri DD, Arnould L, Jacquemier J, Treilleux I, Caldas C, Chin SF, Fatima A, Thompson AM, Stenhouse A, Foekens J, Martens J, Sieuwerts A, Brinkman A, Stunnenberg H, Span PN, Sweep F, Desmedt C, Sotiriou C, Thomas G, Broeks A, Langerod A, Aparicio S, Simpson PT, van ’t Veer L, Eyfjord JE, Hilmarsdottir H, Jonasson JG, Børresen-Dale AL, Ta Michael Lee M, Wong BH, Tee Tan BK, Hooijer GKJ, O’Meara S, Dodoran MS, Teague JW, Butler AP, Iacobuzio-Donahue C, Santarius T, Grundy RG, Malkin D, Greaves M, Munshi N, Flanagan AM, Bowtell D, Martin S, Larsimont D, Reis-Filho JS, Boussioutas A, Taylor JA, Hayes ND, Janes SM, Futreal PA, Stratton MR, McDermott U, Campbell PJ, Oameara S, Dodoran MS, Teague JW, Butler AP, Iacobuzio-Donahue C, Santarius T, Grundy RG, Malkin D, Greaves M, Munshi N, Flanagan AM, Bowtell D, Martin S, Larsimont D, Reis-Filho JS, Boussioutas A, Taylor JA, Hayes ND, Janes SM, Futreal PA, Stratton MR, McDermott U, Campbell PJ, Provenzano E, van de Vijver M, Richardson AL, Purdie C, Pinder S, Grogan G Mac, Vincent-Salomon A, Larsimont D, Grabau D, Sauer T, Garred Ø, Ehinger A, Van den Eynden GG, van Deurzen CHM, Salgado R, Brock JE, Lakhani SR, Giri DD, Arnould L, Jacquemier J, Treilleux I, Caldas C, Chin SF, Fatima A, Thompson AM, Stenhouse A, Foekens J, Martens J, Sieuwerts A, Brinkman A, Stunnenberg H, Span PN, Sweep F, Desmedt C, Sotiriou C, Thomas G, Broeks A, Langerod A, Aparicio S, Simpson PT, van ’t Veer L, Eyfjord JE, Hilmarsdottir H, Jonasson JG, Børresen-Dale AL, Ta Michael Lee M, Wong BH, Tan BKT, Hooijer GKJ. Nat Commun. 2014 Jan;5:3644.

18. Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study. Bhoo-Pathy N, Verkooijen HM, Wong F-Y, Pignol J-P, Kwong A, Tan E-Y, Aishah Taib N, Nei W-L, Ho G-F, Tan B, Chan P, Lee S-C, Hartman M, Yip C-H, Dent R. Int J Cancer. 2015 Nov 15;137(10):2504–12.

19. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Ju YS, Tubio JMCC, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Michael Lee MT, van’t Veer LJ, Tan BKT, Aparicio S, Span PN, Martens JWMM, Knappskog S, Vincent-Salomon A, Børresen-Dale A-LL, Eyfjörd JE, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR, ICGC Prostate Cancer Working Group, ICGC Bone Cancer Working Group, ICGC Breast Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MTM, van’t Veer LJ, Tan BKTT, Aparicio S, Span PN, Martens JWMM, Knappskog S, Vincent-Salomon A, Børresen-Dale A-LL, Eyfjörd JE, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR. Genome Res. 2015 Jun;25(6):814–24.

20. Genomic landscapes of breast fibroepithelial tumors. Tan J, Ong CK, Lim WK, Ng CCY, Thike AA, Ng LM, Rajasegaran V, Myint SS, Nagarajan S, Thangaraju S, Dey S, Nasir NDM, Wijaya GC, Lim JQ, Huang D, Li Z, Wong BH, Chan JYS, McPherson JR, Cutcutache I, Poore G, Tay ST, Tan WJ, Putti TC, Ahmad BS, Iau P, Chan CW, Tang APHH, Yong WS, Madhukumar P, Ho GH, Tan VKM, Wong CY, Hartman M, Ong KW, Tan BKT, Rozen SG, Tan P, Tan PH, Teh BT. Nat Genet. 2015 Nov;47(11):1341–5.

21. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Koh VCY, Lim JCT, Thike AA, Cheok PY, Thu MMM, Tan VKM, Tan BKT, Ong KW, Ho GH, Tan WJ, Tan Y, Salahuddin AS, Busmanis I, Chong APY, Iqbal J, Thilagaratnam S, Wong JSL, Tan PH. Breast Cancer Res Treat. 2015 Jul;152(2):293–304.

22. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1. McPherson JR, Ong C-KK, Ng CC-YY, Rajasegaran V, Heng H-LL, Yu WS-SS, Tan BK-T, Madhukumar P, Teo MC-CC, Ngeow J, Thike A-AA, Rozen SG, Tan P-HH, Lee ASSGS-G, Teh B-TT, Yap Y-SS. Cancer Med. 2015 Oct 3;

23. False negative rate for intraoperative sentinel lymph node frozen section in patients with breast cancer: A retrospective analysis of patients in a single Asian institution. Wong J, Yong WS, Thike AA, Iqbal J, Salahuddin AS, Ho GH, Madhukumar P, Tan BKT, Ong KW, Ta PH, Tan PH. J Clin Pathol. 2015 Jul;68(7):536–40.

24. Differences in Survival of Women with Breast Cancer from Different Ethnic Groups in Singapore- A Population Based Cancer Registry Study and an Institutional Based Review. Tan BKT, Lim GH, Tan PH, Yap YS, Sean YW, Madhukumar P, Wee OK, Chia KS. J Cancer Biol Res. 2015;3(3):1067.

25. Perioperative Outcomes of Therapeutic Breast Surgery in the Elderly. Lee CM, Tan VK, Tan BK, Madhukumar P, Yong WS, Wong CY, Ong KW. Ann Acad Med Singapore. 2016 Jun;45(6):261–3.

26. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GKJ, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O’Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van Den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Veer LV t., Tutt A, Knappskog S, Tan BKT, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, Van De Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Nature. 2016;

27. The curious incident of 3 melanomas and their possible origins - A case report and review of literature. Sin EIL, Tan BKT, Lau KW, Teo MCC. Int J Surg Case Rep. 2016;

28. Breast carcinoma and phyllodes tumour: A case series. Sin EIL, Wong CY, Yong WS, Ong KW, Madhukumar P, Tan VKM, Thike AA, Tan PH, Tan BKT. J Clin Pathol. 2016;

29. Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes. Lim SZ, Selvarajan S, Thike AA, Nasir NDBM, Tan BKT, Ong KW, Tan PH. Breast Cancer Res Treat. 2016;

30. Clinicopathological characteristics and treatment outcomes in patients with stage I-III invasive lobular carcinoma of the breast (ILC) treated at the National Cancer Centre Singapore. Lee JJX, Wong F-Y, Tan B, Lim SH, Tan SH, Ngeow JY, Dent RA. J Clin Oncol. 2016 May 20;34(15_suppl):e12005–e12005.

31. Sarcoma of the breast: an update on a rare entity. Lim SZ, Ong KW, Tan BKT, Selvarajan S, Tan PH. J Clin Pathol. 2016 May;69(5):373–81.

32. An Unusual Case of Small Bowel Obstruction in an Elderly Woman. Tan HL, Tan BKT, Lee SY. Gastroenterology. 2016;150(7):e3–4.

33. Trends in Post-Mastectomy Reconstruction in an Asian Population: A 12-Year Institutional Review. Ng YYR, Tan VKM, Goh TLH, Yong WS, Wong CY, Ho GH, Madhukumar P, Ong KW, Ong YS, Sim Y, Tan BK, Tan BKT. Breast J. 2017 Jan;23(1):59–66.

34. Somatic mutations reveal asymmetric cellular dynamics in the early human embryo. Ju YS, Martincorena I, Gerstung M, Petljak M, Alexandrov LB, Rahbari R, Wedge DC, Davies HR, Ramakrishna M, Fullam A, Martin S, Alder C, Patel N, Gamble S, O’Meara S, Giri DiD, Sauer T, Pinder SE, Purdie CA, Borg Å, Stunnenberg H, Van De Vijver M, Tan BKT, Caldas C, Tutt A, Ueno NT, Van ’T Veer LJ, Martens JWM, Sotiriou C, Knappskog S, Span PN, Lakhani SR, Eyfjörd JE, Børresen-Dale AL, Richardson A, Thompson AM, Viari A, Hurles ME, Nik-Zainal S, Campbell PJ, Stratton MR. Nature. 2017;

35. Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer. Cheng SH-C, Huang T-T, Cheng Y-H, Tan TBK, Horng C-F, Wang YA, Brian NS, Shih L-S, Yu B-L. PLoS One. 2017;12(9):e0184372.

36. Surgery for early breast cancer in the extremely elderly leads to improved outcomes – An Asian population study. Lee CM, Zheng H, Tan VKM, Tan TJY, Kanesvaran R, Wong FY, Sim YR, Yong WS, Madhukumar P, Ong KW, Tan BKT. Breast. 2017;

37. Nipple Reconstruction with Rolled Dermal Graft Support. Tan B-K, Liang W, Madhukumar P, Tan BKT. Nipple-Areolar Complex Reconstruction. 2018.

38. Immediate breast reconstruction following nipple-sparing mastectomy in an asian population: Aesthetic outcomes and mitigating nipple-areolar complex necrosis. Pek WS, Tan BK, Ng YYR, Tan VKM, Rasheed MZ, Tan BKT, Ong KW, Ong YS. Arch Plast Surg. 2018;

39. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours. Sim Y, Tan VKM, Sidek NAB, Chia DKA, Tan BKT, Madhukumar P, Yong WS, Wong CY, Ong KW. ANZ J Surg. 2018;

40. Metastasis of primary lung carcinoma to breast: An unusual presentation. Aw DKL, Leong LCH, Tan KTB. Breast J. 2018;24(3):406–7.

41. A circulating miRNA signature for stratification of breast lesions among women with abnormal screening mammograms. Loke SY, Munusamy P, Koh GL, Chan CHT, Madhukumar P, Thung JL, Tan KTB, Ong KW, Yong WS, Sim Y, Oey CL, Lim SZ, Chan MYP, Ho TSJ, Khoo BKJ, Wong SLJ, Thng CH, Chong BK, Tan EY, Tan VKM, Lee ASG. Cancers (Basel). 2019;

42. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions. Sim Y, Ng GXP, Ng CCY, Rajasegaran V, Wong SF, Liu W, Guan P, Nagarajan S, Ng WY, Thike AA, Lim JCT, Nasir NDBM, Tan VKM, Madhukumar P, Yong WS, Wong CY, Tan BKT, Ong KW, Teh BT, Tan PH. BMC Med Genomics. 2019;12(1):142.

43. Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population. Lin C-H, Yap YS, Lee K-H, Im S-A, Naito Y, Yeo W, Ueno T, Kwong A, Li H, Huang S-M, Leung R, Han W, Tan B, Hu F-C, Huang C-S, Cheng A-L, Lu Y-S, Asian Breast Cancer Cooperative Group. J Natl Cancer Inst. 2019 Dec 1;111(12):1298–306.

44. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours. Lim SZ, Ng CCY, Rajasegaran V, Guan P, Selvarajan S, Thike AA, Nasir NDBM, Koh VCY, Tan BKT, Ong KW, Teh BT, Tan PH. Breast Cancer Res Treat. 2019;

45. Impact of hormonal status on ductal carcinoma in situ of the breast: Outcome and prognostic factors. Tay THC, Ng WY, Ong KW, Wong CY, Tan BKT, Yong WS, Madhukumar P, Tan VKM, Lim SZ, Sim Y. Breast J. 2019;

46. Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing. Kleftogiannis D, Ho D, Liew JX, Poon P, Gan A, Ng RC-H, Tan BK-T, Tay KH, Lim S-H, Tan GS, Shih CC, Lim T, Lee AS-G, Tan I, Yap Y-S, Ng S. bioRxiv. 2019;

47. Genomic characterisation of breast fibroepithelial lesions in an international cohort. Md Nasir ND, Ng CCY, Rajasegaran V, Wong SF, Liu W, Ng GXP, Lee JY, Guan P, Lim JQ, Thike AA, Koh VCY, Loke BN, Chang KTE, Gudi MA, Lian DWQ, Madhukumar P, Tan BKT, Tan VKM, Wong CY, Yong WS, Ho GH, Ong KW, Tan P, Teh BT, Tan PH. J Pathol. 2019;

48. Pseudoaneurysm after vacuum-assisted breast biopsy treated with percutaneous thrombin injection. Xiang F, Gogna A, Leong LCH, Tan BKT. Breast J. 2019;25(2):318–9.

49. A pilot study comparing Sentimag/Sienna versus standard modality for sentinel lymph node identification in patients with breast cancer. Hamzah JL, Tan BKT, Tan V, Madhukumar P, Lim SZ, Sim YR, Yong WS, Lee ZJ, Ong KW. Breast J. 2019 Oct 14;

50. Breast calcifications in patients with end-stage renal disease. Basu P, Leong LCH, Tan BY, Tan BKT. Breast J. 2019;25(3):515–6.

51. Surgical and oncological safety of nipple-sparing mastectomy in an Asian population. Ng YY-R, Tan VK-M, Pek WS, Chang JH-E, Sim Y, Ong KW, Yong WS, Madhukumar P, Wong CY, Ong YS, Tan BK, Tan BKT. Breast Cancer. 2019 Mar;26(2):165–71.

52. Unusual case of massive lower gastrointestinal bleeding in a young woman. Toh BC, Chew MH, Tan BKT. ANZ J Surg. 2019 Jun 20;

53. Behaviour and characteristics of low-grade ductal carcinoma in situ of the breast: literature review and single-centre retrospective series. Koh VCY, Lim JCT, Thike AA, Cheok PY, Thu MMM, Li H, Tan VKM, Ong KW, Tan BKT, Ho GH, Thilagaratnam S, Wong JSL, Wong FY, Ellis IO, Tan PH. Histopathology. 2019 Jun;74(7):970–87.

54. Impact of deviation from guideline recommended treatment on breast cancer survival in Asia. Ho PJ, Ow SGW, Sim Y, Liu J, Lim SH, Tan EY, Tan S-M, Lee SC, Tan VK-M, Yap Y-S, Chay WY, Tan BKT, Wong FY, Li J, Hartman M. Sci Rep. 2020 Jan 28;10(1):1330.

55. Pan-cancer analysis of whole genomes. ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature. 2020;578(7793):82–93.

56. A tripartite approach can seek to optimize breast cancer management during a pandemic – Real‐Time experience of a developing breast oncology unit in Singapore. Ngaserin S, Chua HW, Chew M, Tan BK. Breast J. 2020 Jul;tbj.13961.

57. Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience. Kee G-J, Tan RY-C, Rehena S, Lee JJ-X, Zaw MW-W, Lian W-X, Yeong J, Tan S-M, Lim S-H, Tan BK-T, Yap Y-S, Dent RA, Wong F-Y, Lee G-E. World J Clin Oncol. 2020 May 24;11(5):283–93.

58. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women. Ho W-K, Tan M-M, Mavaddat N, Tai M-C, Mariapun S, Li J, Ho P-J, Dennis J, Tyrer JP, Bolla MK, Michailidou K, Wang Q, Kang D, Choi J-Y, Jamaris S, Shu X-O, Yoon S-Y, Park SK, Kim S-W, Shen C-Y, Yu J-C, Tan EY, Chan PMY, Muir K, Lophatananon A, Wu AH, Stram DO, Matsuo K, Ito H, Chan CW, Ngeow J, Yong WS, Lim SH, Lim GH, Kwong A, Chan TL, Tan SM, Seah J, John EM, Kurian AW, Koh W-P, Khor CC, Iwasaki M, Yamaji T, Tan KMV, Tan KTB, Spinelli JJ, Aronson KJ, Hasan SN, Rahmat K, Vijayananthan A, Sim X, Pharoah PDP, Zheng W, Dunning AM, Simard J, van Dam RM, Yip C-H, Taib NAM, Hartman M, Easton DF, Teo S-H, Antoniou AC. Nat Commun. 2020 Dec 31;11(1):3833.

59. Sex differences in oncogenic  mutational processes. Li CH, Prokopec SD, Sun RX, Yousif F, Schmitz N, Boutros PC. PCAWG Consortium. Nat Commun. 2020 Aug 28;11(1):4330. doi: 10.1038/s41467-020-17359-2. PubMed PMID: 32859912; PubMed Central PMCID: PMC7455744.

60. Effects of housing value and medical subsidy on treatment and outcomes of breast cancer patients in Singapore: A retrospective cohort study. Wong FY, Wong RX, Zhou S, Ong WS, Pek PP, Yap YS, Tan BKT, Ngeow JYY, Tan VKM, Sim Y, Tan SM, Lim SH, Madhukumar P, Tan TJY, Loh KW, Ong MEH, Wong TH; Joint Breast Cancer Registry collaborators. Lancet Reg Health West Pac. 2021 Jan;6:100065. doi: 10.1016/j.lanwpc.2020.100065.

61. Study protocol: a pilot quasi-experimental trial of tele-rehabilitation and tele-drain care post-mastectomy. Asano M, Koh GC, Madhukumar P, Teng GYH, Liew PLL, Nagalingam S, Tan MLM, Ng YS, Tan BKT. Pilot Feasibility Stud. 2021 Feb 1;7(1):39. doi: 10.1186/s40814-021-00776-5.

62. Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore. Ng PS, Boonen RA, Wijaya E, Chong CE, Sharma M, Knaup S, Mariapun S, Ho WK, Lim J, Yoon SY, Mohd Taib NA, See MH, Li J, Lim SH, Tan EY, Tan BK, Tan SM, Tan VK, van Dam RM, Rahmat K, Yip CH, Carvalho S, Luccarini C, Baynes C, Dunning AM, Antoniou A, van Attikum H, Easton DF, Hartman M, Teo SH. J Med Genet. 2021 Apr 2:jmedgenet-2020-107471. doi: 10.1136/jmedgenet-2020-107471. Epub ahead of print.

63. Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers. Ho PJ, Yeoh YS, Miao H, Lim SH, Tan EY, Tan BKT, Tan VKM, Tan SM, Yong WS, Wong FY, Madhukumar P, Chan CW, Iau PTC, Lee SC, Putti T, Buhari SA, Lee JY, Lim GH, Woo E, Yan Z, Chan PMY, Chen JJC, Lu SQ, Dent R, Lee WP, Mok CW, Seah JCM, Sim X, van Dam RM, Chia KS, Li J, Hartman M. PLoS One. 2021 Apr 26;16(4):e0250102. doi: 10.1371/journal.pone.0250102.

64. Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer. Zou R, Loke SY, Tan VK, Quek ST, Jagmohan P, Tang YC, Madhukumar P, Tan BK, Yong WS, Sim Y, Lim SZ, Png E, Lee SYS, Chan MYP, Ho TSJ, Khoo BKJ, Wong SLJ, Thng CH, Chong BK, Teo YY, Too HP, Hartman M, Tan NC, Tan EY, Lee SC, Zhou L, Lee ASG. Cancers (Basel). 2021 Apr 28;13(9):2130. doi: 10.3390/cancers13092130

65. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing. Ng CCY, Md Nasir ND, Loke BN, Tay TKY, Thike AA, Rajasegaran V, Liu W, Lee JY, Guan P, Lim AH, Chang KTE, Gudi MA, Madhukumar P, Tan BKT, Tan VKM, Wong CY, Yong WS, Ho GH, Ong KW; International Fibroepithelial Consortium, Yip GWC, Bay BH, Tan P, Teh BT, Tan PH. Mod Pathol. 2021 Jul;34(7):1320-1332. doi: 10.1038/s41379-021-00787-w. Epub 2021 Mar 16.

66. DNA methylation and breast cancer-associated variants.  Ho PJ, Dorajoo R, Ivanković I, Ong SS, Khng AJ, Tan BK, Tan VKM, Lim SH, Tan EY, Tan SM, Tan QT,  Yan Z, Ngeow J, Sim Y, Chan P, Chuan JCJ, Chan CW, Tang SW, Hartman M, Li J. Breast Cancer Res Treat. 2021 Aug;188(3):713-727. doi: 10.1007/s10549-021-06185-9. Epub 2021 Mar 26.

67. Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy. Lim SZ, Kusumawidjaja G, Mohd Ishak HM, Tan BKT, Tan SY, Hamzah JL, Madhukumar P, Yong WS, Wong CY, Sim Y, Lim GH, Lim SH, Tan SM, Wong FY, Tan VKM. Breast Cancer Res Treat. 2021 Oct;189(3):837-843. doi: 10.1007/s10549-021-06341-1. Epub 2021 Aug 3

68.  Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer. Loo SY, Toh LP, Xie WH, Pathak E, Tan W, Ma S, Lee MY, Shatishwaran S, Yeo JZZ, Yuan J, Ho YY, Peh EKL, Muniandy M, Torta F, Chan J, Tan TJ, Sim Y, Tan V, Tan B, Madhukumar P, Yong WS, Ong KW, Wong CY, Tan PH, Yap YS, Deng LW, Dent R, Foo R, Wenk MR, Lee SC, Ho YS, Lim EH, Tam WL.  Sci Adv. 2021 Oct 8;7(41):eabh2443. doi: 10.1126/sciadv.abh2443. Epub 2021 Oct 6.

69. Germline breast cancer susceptibility genes, tumor characteristics, and survival. Ho PJ, Khng AJ, Loh HW, Ho WK, Yip CH, Mohd-Taib NA, Tan VKM, Tan BK, Tan SM, Tan EY, Lim SH, Jamaris S, Sim Y, Wong FY, Ngeow J, Lim EH, Tai MC, Wijaya EA, Lee SC, Chan CW, Buhari SA, Chan PMY, Chen JJC, Seah JCM, Lee WP, Mok CW, Lim GH, Woo E, Kim SW, Lee JW, Lee MH, Park SK, Dunning AM, Easton DF, Schmidt MK, Teo SH, Li J, Hartman M. Genome Med. 2021 Dec 2;13(1):185. doi: 10.1186/s13073-021-00978-9. PMID: 34857041; PMCID: PMC8638193.

70. COVIDSurg Collaborative; GlobalSurg Collaborative. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560. Epub 2021 Aug 9. PubMed PMID: 34371522.

 71. COVIDSurg Collaborative; GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101. PubMed PMID:33761533; PubMed Central PMCID: PMC7995808.

 72. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. COVIDSurg Collaborative; GlobalSurg Collaborative. Anaesthesia. 2021 Jun;76(6):748-758. doi: 10.1111/anae.15458. Epub 2021 Mar 9. PubMed PMID: 33690889; PubMed Central PMCID: PMC8206995.

73. Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients. Lim ZL, Ho PJ, Khng AJ, Yeoh YS, Ong ATW, Tan BKT, Tan EY, Tan SM, Lim GH, Lee JA,Tan VK, Hu J, Li J, Hartman M. BMC Med. 2022 Aug 4;20(1):239. doi: 10.1186/s12916-022-02440-y. PubMed PMID: 35922814; PubMed Central PMCID: PMC9351273.

74. Male breast cancer: a Singapore perspective. Lim JSH, Sim Y, Ngeow J, Yuen J, Tan VKM, Tan BKT, Yong WS, Wong CY, Lim SZ, Hamzah JLB, Tan SY, Wong FY, Madhukumar P. ANZ J Surg. 2022 Jun;92(6):1440-1446. doi: 10.1111/ans.17737. Epub 2022 Apr 25. PubMed PMID: 35470542.

75.  Association between Breast Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results. Ong SS, Ho PJ, Khng AJ, Lim EH, Wong FY, Tan BK, Lim SH, Tan EY, Tan SM, Tan VKM, Dent R, Tan TJY, Ngeow J, Madhukumar P, Hamzah JLB, Sim Y, Lim GH, Pang JS, Alcantara VS, Chan PMY, Chen JJC, Kuah S, Seah JCM, Buhari SA, Tang SW, Ng CWQ, Li J, Hartman M.  Cancers (Basel). 2022 May 31;14(11). doi: 10.3390/cancers14112714. PubMed PMID: 35681694; PubMed 
 Central PMCID: PMC9179461.

76. Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer. Ang BH, Ho WK, Wijaya E, Kwan PY, Ng PS, Yoon SY, Hasan SN, Lim JMC, Hassan T, Tai MC, Allen Lee A, Taib NAM, Yip CH, Hartman M, Lim SH, Tan EY, Tan BKT, Tan SM, Tan VKM, Ho PJ, Khng AJ, Dunning AM, Li J, Easton DF, Antoniou AC, Teo SH. J Clin Oncol. 2022 May 10;40(14):1542-1551. doi: 10.1200/JCO.21.01647. Epub 2022 Feb 10. PubMed 
 PMID: 35143328.

77. Impact of Subsidy on the Use of Personalized Medicine in Breast Cancer. Value Health Reg Issues. Lim JT, Koh JJE, Ho PJ, Liu J, Lim SH, Tan EY, Tan BKT, Tan VKM, Tan SM, Yong WS, Hartman M, Chen C. 2022 May;29:108-115. doi: 10.1016/j.vhri.2021.10.002. Epub 2022 Jan 29. PubMed PMID:35104748.

78. Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification. Ho PJ, Ho WK, Khng AJ, Yeoh YS, Tan BK, Tan EY, Lim GH, Tan SM, Tan VKM, Yip CH, Mohd-Taib NA, Wong FY, Lim EH, Ngeow J, Chay WY, Leong LCH, Yong WS, Seah CM, Tang  SW, Ng CWQ, Yan  Z, Lee JA, Rahmat K, Islam T, Hassan T, Tai MC, Khor CC, Yuan JM, Koh WP, Sim X, Dunning AM, Bolla MK, Antoniou AC, Teo SH, Li J,Hartman M. BMC Med. 2022 Apr 26;20(1):150. doi: 10.1186/s12916-022-02334-z. PubMed PMID: 35468796; PubMed Central PMCID: PMC9040206.

 79. The Impact of Statin Use and Breast Cancer Recurrence - A Retrospective Study in Singapore. Sim Y, Lim C, Phyu N, Tan KTB, Chew LST, Wong CY, Madhukumar P, Yong WS, Lim SZ, Hamzah JLB, Tan SY, Chay WY, Wong FY, Tan PH, Tan VKT. Front Oncol. 2022;12:835320. doi: 10.3389/fonc.2022.835320. eCollection 2022. PubMed PMID: 35433431; PubMed Central PMCID: PMC9008885.

 80.  Associations between Pre-Diagnostic Physical Activity with Breast Cancer Characteristics and Survival. Lim ZL, Lim GH, Ho PJ, Khng AJ, Yeoh YS, Ong ATW, Tan BKT, Tan EY, Tan SM, Tan VK, Li J, Hartman M. Cancers (Basel). 2022 Mar 30;14(7). doi: 10.3390/cancers14071756. PubMed PMID:35406528; PubMed Central PMCID: PMC8997033.

 81. Polygenic risk scores for prediction of breast cancer risk in Asian populations. Ho WK, Tai MC, Dennis J, Shu X, Li J, Ho PJ, Millwood IY, Lin K, Jee YH, Lee SH, Mavaddat N, Bolla MK, Wang Q, Michailidou K, Long J, Wijaya EA, Hassan T, Rahmat K, Tan VKM, Tan BKT, Tan SM, Tan EY, Lim SH, Gao YT, Zheng Y, Kang D, Choi JY, Han W, Lee HB,  Kubo M, Okada Y,  Namba S, Park SK, Kim SW, Shen CY, Wu PE, Park B, Muir KR, Lophatananon A, Wu AH, Tseng CC, Matsuo K, Ito H, Kwong A, Chan TL, John EM, Kurian. AW, Iwasaki M, Yamaji T, Kweon SS, Aronson KJ, Murphy RA, Koh WP, Khor CC, Yuan JM, Dorajoo R, Walters RG, Chen Z, Li L, Lv J, Jung KJ, Kraft P, Pharoah PDB, Dunning AM, Simard J, Shu XO, Yip CH, Taib NAM, Antoniou AC, Zheng W, Hartman M, Easton DF, Teo SH. Genet Med. 2022 Mar;24(3):586-600. doi: 10.1016/j.gim.2021.11.008. Epub 2021 Dec 15.PubMed PMID: 34906514;  PubMed Central PMCID: PMC7612481.

82. Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision. Bong TSH, Tan JKT, Ho JTS, Tan PH, Lau WS, Tan TM, Wong JSL, Tan VKM, Tan BKT, Madhukumar P, Yong WS, Lim SZ, Wong CY, Ong KW, Sim Y. J Breast Cancer. 2022 Feb;25(1):37-48. doi: 10.4048/jbc.2022.25.e7. PubMed PMID:35199500; PubMed Central PMCID: PMC8876544.

83. COVIDSurg Collaborative; GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24. PubMed PMID:34428858; PubMed Central PMCID: PMC8652887.

84. Relevance of the MHC region for breast cancer susceptibility in Asians. Ho PJ, Khng AJ, Tan BK, Tan EY, Tan SM, Tan VKM, Lim GH, Aronson KJ, Chan TL, Choi JY, Dennis J, Ho WK, Hou MF, Ito H, Iwasaki M, John EM, Kang D, Kim SW, Kurian AW, Kwong A, Lophatananon  A, Matsuo K, Mohd-Taib NA, Muir K, Murphy RA, Park SK, Shen CY, Shu XO, Teo SH, Wang Q, Yamaji T, Zheng W, Bolla MK, Dunning AM, Easton DF, Pharoah PDP, Hartman M, Li J. Breast Cancer. 2022 Sep;29(5):869-879. doi: 10.1007/s12282-022-01366-w. Epub 2022  May 11. PubMed PMID: 35543923; PubMed Central PMCID: PMC9385763

85. It Will Lead You to Make Better Decisions about Your Health"A Focus Group and Survey Study on Women's   Attitudes towards Risk-Based Breast Cancer Screening and Personalised Risk Assessments. Jonathan Jun Kit Liow, Zi Lin Lim, Tomiko Mei Ying Sim, Peh Joo Ho, Su-Ann Goh, Sheen Dian Choy, Ying Jia Chew, Benita Kiat-Tee Tan, Veronique Kiak Mien Tan, Mikael Hartman, Keri McCrickerd, Jingmei Li. Current oncology (toronto ,ont), 9181-9198, 29(12), 2022 Nov.

86. Attitudes and barriers to mammography screening in Singaporean women through the eyes of their adult children: A focus group study. Jonathan Jun Kit Liow , Zi Lin Lim, Peh Joo Ho, Su-Ann Goh, Shravya Murali , Benita Kiat Tee Tan, Veronique Kiak Mien Tan, Mikael Hartman, Jingmei Li, Keri McCrickerd SSM Qualitative Research in Health .Elsevier, Dec 2022, 100168 https://doi.org/10.1016/j.ssmqr.2022.100168

87. Profiling Microbial Communities in Idiopathic Granulomatous Mastitis. Seeu Si Ong, Jia Xu, Choon Kiat Sim, Alexis Jiaying Khng, Peh Joo Ho, Philip Kam Weng Jwan, Aarathi RavikrishnN, Kiat-Tee Bwnita Tan, Qing Ting Tan, Ern Yu Tan, Su-Ming Tan, Thomas ChodaRY Putti, Swee Ho Lim, Ee Ling Serene Tang, Niranjan Nagarajan, Neerja Karnani, Jingmei Li, Mikael Hartman Int J Mol Sci 2023 Jan 5;24(2):1042. doi: 10.3390/ijms24021042 PMCID: PMC9863225; PMID: 36674562

88. A Preliminary Experience of Endoscopic Total Mastectomy With Immediate Free Abdominal-Based Perforator Flap Reconstruction Using Minimal Incisions, and Literature Review. Ngaserin S, Wong AW, Leong FQ, Feng JJ, Kok YO, Tan BK. J Breast Cancer. 2023; Published online March 13, 2023, https://doi.org/10.4048/jbc.2023.26.e10, PIMD:7051645

89. Encapsulated papillary carcinoma of the breast: An institutional case series and literature review. Hiang Jin Tan, Puay Hoon Tan, Lester Chee Hao Leong, Veronique Kiak Mien Tan, Benita Kiat Tee Tan, Sue Zann Lim, Madhukumar Preetha, Chow Yin Wong, Wei Sean Yong, Yirong Sim Cancer Medicine, 31 March 2023. https://doi.org/10.1002/cam4.5855, 

Research Trials